$9.61
0.141.53%
Ult. Agg.: Oct 23, 4:04 PM
Gossamer Bio (GOSS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.17 | $-0.20 | $-0.19 |
| Actual | $-0.08 | $-0.20 | $-0.21 | $-0.21 |
| Surprise | +33.3% | -17.6% | -5.00% | -10.5% |
| Revenue | ||||
| Estimate | $3.6M | $4.9M | $7.6M | $6.3M |
| Actual | $9.2M | $17.0M | $13.8M | $13.3M |
| Surprise | +157.8% | +243.0% | +82.7% | +112.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-4.26 | $-4.91 | $-5.07 | $-5.15 |
| Revenue | ||||
| Consensus | $10.7M | $3.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.08 | $-0.12 | 33.3 % |
| Q1 | May 15, 2026 | $-0.20 | $-0.17 | -17.6 % |
| Q4 | Mar 17, 2026 | $-0.21 | $-0.20 | -5.00 % |
| Q3 | Nov 5, 2025 | $-0.21 | $-0.19 | -10.5 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $9.24M | $3.58M | 157.8 % |
| Q1 | May 15, 2026 | $16.95M | $4.94M | 243.0 % |
| Q4 | Mar 17, 2026 | $13.80M | $7.55M | 82.7 % |
| Q3 | Nov 5, 2025 | $13.29M | $6.26M | 112.3 % |